Jeffrey Hubbell, the MacLean Professor of Molecular Engineering Innovation and Enterprise, has recently won the Society for Biomaterials' 2017 Founders Award, which is the largest award given by the Society for Biomaterials. Specifically, the award is given to those individuals who have made "long-term, landmark contributions to the discipline of biomaterials."
Professor Hubbell designs materials to assemble in such a way that they can stimulate the immune systems to fight infection or malignancy, or turn off some aspects of the immune system to address auto-immune diseases such as type-1 diabetes. He has coined the term “immuno-modulatory materials” to describe this newly emerging field of research. Along with his associates, he holds 77 patents. In addition, Hubbell is also an entrepreneurial materials scientist and has founded three companies based on his research. For more on Professor Hubbell's research, please visit his lab website here.
Congratulations to Professor Hubbell for this prestigious honor!